Kristie Wagner
Keine laufenden Positionen mehr
Profil
Kristie Wagner worked as Vice President & Controller at Akebia Therapeutics, Inc. from 2013 to 2021, and then as Vice President & Controller at Entasis Therapeutics Holdings, Inc. in 2021-2022.
She holds a Master's in Business Administration from Suffolk University and an undergraduate degree from Massachusetts College of Liberal Arts.
Ehemalige bekannte Positionen von Kristie Wagner
Unternehmen | Position | Ende |
---|---|---|
AKEBIA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01.02.2021 |
ENTASIS THERAPEUTICS HOLDINGS INC. | Director of Finance/CFO | - |
Ausbildung von Kristie Wagner
Suffolk University | Masters Business Admin |
Massachusetts College of Liberal Arts | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AKEBIA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Entasis Therapeutics Holdings, Inc.
Entasis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections. Its anti-infective discovery platform has produced a pipeline of differentiated programs, which is bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), Non-Beta-lactam PBP inhibitor, and Zoliflodacin. The company was founded in May 2015 and is headquartered in Waltham, MA. | Health Technology |